May 22, 2017 6:38 PM ET

Capital Markets

Company Overview of SK Capital Partners

Company Overview

SK Capital Partners is a private equity firm specializing in investing in recapitalizations, industry consolidation, businesses in transition, growth equity investments, corporate spinouts, corporate carveouts, multinational companies, partnerships with family-owned businesses or entrepreneurs, and control buyouts in mature and middle market companies. It seeks to invest in specialty material and chemicals, healthcare, supply chain and logistics, aerospace and defence, and information and technology sectors. Within specialty material and chemicals, the firm seeks to invest in personal care ingredients, nutrition and food ingredients, flavors and fragrances, agrochemicals, plastics, composite...

400 Park Avenue

Suite 810

New York, NY 10022

United States

Founded in 2007





Key Executives for SK Capital Partners

Co-Founder, President, and Managing Director
Co-Founder, Founding Partner, and Managing Director
Chief Financial Officer
Operating Partner and General Counsel
Managing Director
Compensation as of Fiscal Year 2016.

SK Capital Partners Key Developments

SK Capital Puts Archroma Up For Sale In 2017.

SK Capital Partners put Archroma Management LLC up for sale earlier this year, hiring Evercore and HSBC to find a buyer for the company, which could fetch around $1.5 billion. The company is due to attract both corporate and sponsors buyers and first round bids were due last week, one of the sources said. SK Capital was not immediately available to comment.

Synthomer Mulls Bid For Archroma Unit

Synthomer plc (LSE:SYNT) is considering a bid for a textile chemicals business valued at about $1.5 billion that’s been put up for sale by SK Capital Partners LP, according to three people with knowledge of the situation. Representatives for Synthomer and SK Capital declined to comment. Preliminary bids for Archroma Management LLC are due in the coming days. SK Capital could potentially retain a stake if it goes ahead with a transaction, they said.

SK Capital Reportedly Put Archroma Management For Sale

SK Capital Partners has put Archroma Management LLC up for sale in a move that could potentially fetch CHF 1.5 billion, people close to the matter said. SK Capital has asked Evercore and HSBC to find a buyer for a minority or majority stake in Archroma. SK Capital and HSBC declined to comment, while Evercore was not immediately available for comment.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

February 2, 2017
Niacet Corporation
August 2, 2016
Calabrian Corporation

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SK Capital Partners, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at